Preterian

Quick links to important sections

Preterian

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Preterian

Quick Facts

Property Description
Active Ingredients Perindopril and Indapamide
Form Tablet
Pharmacological Class Antihypertensive agent (ACE Inhibitor + Thiazide-like Diuretic)
General Purpose Management of Essential Hypertension
Origin Synthetic

What Type of Medicine is Preterian and How is it Classified?

Preterian is a synthetic prescription-only drug defined as an antihypertensive agent used to manage sustained elevated blood pressure, or essential hypertension. It is a single-pill combination (SPC) product, which integrates two active ingredients from distinct pharmacological groups into one tablet. The formulation combines an Angiotensin-Converting Enzyme (ACE) Inhibitor with a Thiazide-like Diuretic. This combination is clinically recognized for providing enhanced efficacy in patients who have not achieved adequate control with monotherapy.


Active Ingredients and the Fixed-Dose Combination

The foundational composition of Preterian consists of Perindopril and Indapamide, which are prepared for the oral route of administration. The use of this fixed-dose combination is a defining characteristic, as it ensures the required simultaneous delivery of both compounds—a critical factor for achieving the necessary additive synergy. Perindopril acts as a prodrug that the body converts into its active molecule, and Indapamide is a chlorosulfamoyl derivative. This specific pairing is also marketed under the trade names Noliprel and Coversyl Plus, indicating its widespread adoption.


The Dual-Action Antihypertensive Strategy

The overarching general purpose of Preterian is to achieve comprehensive blood pressure reduction through its distinct dual-action mechanism. The Perindopril component works by promoting vasorelaxation, which helps widen blood vessels and lowers the resistance to blood flow. Concurrently, Indapamide exerts its natriuretic properties, leading to a beneficial reduction in the fluid volume circulating in the body. This combination effectively targets both the vascular tone and fluid dynamics, providing a robust approach to managing the risks associated with long-term high blood pressure.

What side effects are possible with Preterian?

Possible Side Effects and Safety Information

The official safety documentation for Preterian, a fixed-dose combination of Perindopril and Indapamide, classifies possible adverse reactions by frequency and the body system affected. This classification helps structure the medicine's risk profile based on regulatory findings.


Frequency-Classified Adverse Reactions

Adverse effects listed as Common (occurring in 1 in 100 to 1 in 10 patients) typically involve the Nervous System (headache, dizziness), the Respiratory System (cough), and Gastrointestinal Disorders (nausea, constipation). Uncommon reactions include sleep disturbances, mood changes, bronchospasm, and hypersensitivity reactions like urticaria. The most severe, though Very Rare (less than 1 in 10,000 patients), events are generally confined to specialized reports.


Serious Adverse Reactions and Safety Constraints

The regulatory label documents the potential for serious adverse reactions, most notably Angioedema, a rapid swelling of the face, limbs, or airways, which is considered a medically critical event. Severe Hypotension (excessive drops in blood pressure) is also documented, particularly at the initiation of treatment or following dose adjustments.

Safety data defines specific limitations for use. The medicine is contraindicated in patients with a prior history of angioedema linked to ACE inhibitor use, and in individuals with severe renal impairment or severe hepatic impairment. Furthermore, its use is restricted during the second and third trimesters of pregnancy.

Overdose and Emergency Response

A regulatory review of the overdose profile for Preterian, the combination of Perindopril and Indapamide, confirms that the most likely clinical manifestation of acute overdose is severe hypotension (excessively low blood pressure). This condition may be accompanied by severe dizziness, confusion, weakness, and signs of dehydration. The physiological consequences can include oliguria (decreased urine output) and severe disturbances in the electrolyte balance, specifically hypokalemia and hyponatremia.

The officially documented severe outcomes of profound overdose include the potential for acute renal failure and, secondary to extreme blood pressure drops, myocardial infarction or cerebrovascular accident.

In the event of suspected overdose, immediate medical attention must be sought. Official guidance mandates contacting emergency services (such as 911 or equivalent) if the individual exhibits severe clinical signs like passing out or experiencing trouble breathing. Management is defined as symptomatic and supportive treatment, as no specific antidote is documented in the regulatory information. Procedures may include placing the individual in a supine position and administering intravenous saline to correct volume depletion, with close hospital monitoring of renal function and serum electrolytes being required. Specific considerations note that children who have accidentally ingested the drug may require observation in a healthcare facility.

Therapeutic Uses of Preterian

Preterian is commonly used for the long-term management of essential hypertension, a condition characterized by sustained, chronic elevation of blood pressure. The medication is commonly used, particularly when a single agent is not adequate for control. The combination helps address the chronic burden placed on the heart and arterial system. This support assists with maintaining functional stability and contributes to easing the symptoms related to systemic imbalance caused by high pressure.

The primary therapeutic applications include treating essential hypertension, supporting patients whose blood pressure is uncontrolled by monotherapy, and plays a role in managing the risk of cardiovascular and cerebrovascular events. This approach is relevant in clinical scenarios where high blood pressure is coupled with a high cardiovascular risk profile, such as a history of stroke or established vascular disease. The treatment may assist in reducing the likelihood of future health crises like heart attack and stroke.

“This medication is used for managing the symptoms related to systemic imbalance caused by high pressure and supports a more manageable long-term health outlook.”


Quick Fact: Relief for Sustained Vascular Strain
The medication supports general well-being during symptomatic phases by easing the chronic burden of high pressure.

Regulatory References

  1. Health Canada Product Monograph

Eligibility and Restrictions for Use

Eligibility Profile

Preterian is officially labeled for use in adult patients for the management of essential hypertension. Regulatory documents define strict population restrictions and contraindications that determine a patient’s eligibility.

Contraindicated Populations

Use of Preterian is strictly contraindicated for several groups. This includes patients with a history of angioedema (swelling) related to any previous ACE inhibitor, or known hypersensitivity to perindopril, indapamide, or any sulphonamide derivative. It is also prohibited for individuals with severe hepatic impairment or severe renal impairment (creatinine clearance below 30 mL/min), and those with hypokalaemia (low potassium levels). Use is contraindicated during the second and third trimesters of pregnancy and while lactating.

Restricted and Non-Established Use

Preterian is not recommended for the pediatric population (children and adolescents) as its safety and efficacy in this age group have not been established. Use during the first trimester of pregnancy is also not recommended. Patients with moderate renal impairment or those taking specific co-medications, such as sacubitril/valsartan, are subject to further restrictions or absolute contraindications.

What should I know about interactions with other medicines?

Preterian is a combination of perindopril (an ACE inhibitor) and indapamide (a diuretic), and its activity can be significantly altered by co-administered drugs. Always inform your healthcare provider about all prescription, over-the-counter medications, and herbal supplements you are taking.

Combinations to Avoid

  • Lithium: Concurrent use is not recommended as it can increase blood lithium levels and the risk of toxicity, requiring frequent monitoring.
  • Potassium-Sparing Diuretics, Potassium Supplements, or Potassium Salts: These should be avoided as they significantly increase the risk of high serum potassium (hyperkalemia), which can be fatal.
  • Aliskiren or Angiotensin II Receptor Blockers (ARBs): The combination with perindopril is generally not recommended, particularly in patients with kidney problems or diabetes, due to an increased risk of low blood pressure, high potassium, and worsening kidney function.

Combinations Requiring Precaution

  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): NSAIDs, including high-dose acetylsalicylic acid (aspirin), can reduce the blood pressure-lowering effect of Preterian and increase the risk of acute renal failure and hyperkalemia.
  • Antidiabetic Agents (Insulin, Sulfonylureas): Concurrent use can enhance the hypoglycemic effect (low blood sugar). Blood sugar should be monitored closely.
  • Baclofen, Tricyclic Antidepressants, and Sedatives: These can increase the risk of excessive lowering of blood pressure (hypotension).
  • Corticosteroids and Tetracosactide: These may reduce the antihypertensive effect.
  • Medications Causing Torsades de Pointes or Hypokalemia: Caution is required with drugs that can cause an irregular heart rhythm (like certain antiarrhythmics or antipsychotics) or lead to low potassium levels (like certain laxatives or Amphotericin B), as Preterian's indapamide component affects electrolyte balance.

Mechanism of Action

How Preterian Works: Mechanism of Action

Preterian modulates physiological function via a dual mechanism targeting both central and peripheral systems. The drug acts within the Central Nervous System (CNS) as a Positive Allosteric Modulator (PAM) of GABA-A receptors (primarily those containing the alpha1, alpha2, and alpha3 subunits). Binding to these receptors enhances the inhibitory effect of GABA, increasing neuronal influx of chloride ions ( Cl^-), which results in hyperpolarization and a reduced neuronal firing rate.

Simultaneously, Preterian functions as a blocker of the voltage-gated L-type Calcium Channels ( Ca^2+). In the CNS, blocking these channels dampens excitatory neurotransmitter release, contributing to the overall decreased CNS excitability. Peripherally, this action in vascular smooth muscle cells inhibits the calcium influx necessary for contraction, leading to vasodilation and a subsequent decreased systemic vascular resistance. The collective physiological consequences of this dual cascade include reduced arousal, decreased reactivity, and reduced skeletal muscle tone.

Dosage and Administration Information

Administration Scope

Instruction Detail
Route and Form Preterian is administered via the oral route as a fixed-dose tablet containing Perindopril and Indapamide.
Dosing Schedule The standard starting dose is one tablet of 2 mg/0.625 mg once daily. Doses are sequentially titrated upward based on the individual's response, with the highest available combination strength being 8 mg/2.5 mg once daily.
Contextual Timing The medicine must be taken once daily and preferably in the morning. Administration should occur before a meal to prevent food from decreasing the absorption of Perindopril.
Administration The tablet must be swallowed whole with water and should not be crushed or split.
Population Rules Treatment in older adults typically begins at the lowest strength (2 mg/0.625 mg) with attention to renal function. For patients with moderate renal impairment (creatinine clearance 30-60 mL/min), careful dose titration with the lowest strength is required.
Procedural Notes If a dose is missed, it should only be taken if the next scheduled dose is more than 6 hours away; otherwise, it must be skipped. When initiating treatment, any prior diuretic therapy is typically discontinued for 2-3 days beforehand.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Oral
Frequency pattern Once daily
Regulatory basis Governed by established prescribing and product monograph guidelines.
Use-context constraints Administration is subject to time-of-day (morning) and food relationship (before meal) constraints.

Resulting Procedural Structure

Official step sequence:

  • Take one tablet once daily in the morning.
  • Swallow the tablet whole with water.
  • Consume the dose strictly before a meal.

Recent Clinical Evidence

Preterian: Recent Clinical Evidence


Overview of Research for Blood Pressure Control (Essential Hypertension)

The evidence base for this combination medicine, Perindopril/Indapamide, was built upon studies relevant to sustained high blood pressure, or Essential Hypertension, primarily relying on Randomized Controlled Trials (RCTs). These studies were set up to explore the effects of the combination compared to a placebo (an inactive pill) or to other single-drug treatments. Researchers monitored specific physiological measurements and outcomes, such as changes in Systolic and Diastolic Blood Pressure (SBP/DBP), measured both in a clinic setting and sometimes continuously over 24 hours. Studies monitored whether participants could reach predetermined Blood Pressure Target Goals.

Studies reported measurements where the proportion of patients who reached specific blood pressure goals was tracked and reported among groups receiving the combination versus those receiving an inactive pill. This evidence contributes to understanding symptom patterns over defined time intervals, often lasting up to nine months. However, the evidence is limited concerning extremely long-term maintenance of blood pressure control over multiple decades, and data for children remain insufficient.


Research on Cardiovascular Risk Management (High-Risk Patients)

Research went beyond blood pressure measurement. The combination was evaluated in large-scale, long-term clinical studies designed to track the occurrence of Major Cardiovascular Events. These research scenarios focused on high-risk adults defined by established conditions, such as having Type 2 Diabetes Mellitus, or a History of Stroke or Transient Ischemic Attack (TIA).

The outcomes studied focused on major clinical endpoints, including the occurrence of Stroke, Myocardial Infarction (heart attack), and Cardiovascular Death. Research highlights changes measured during the study period. Studies reported that the number of major cardiovascular events recorded for the combination group was tracked against the number recorded for control groups in the high-risk populations studied. The observed incidence of fatal and non-fatal strokes was reported to be lower among the cohorts examined.


What Remains Uncertain About the Research Base

While research provides insight into short-term changes and long-term event tracking, there are still areas where data are still emerging or remain insufficient. Long-term effects are not fully established for the entire duration of a patient's life, and continuous research is ongoing. Furthermore, some core findings were based on a perindopril-based regimen where the fixed combination was used but was not always the only fixed-dose comparator, meaning comparative evidence for specific alternative fixed-dose combinations is lacking.

Key Studies & References Health Canada Product Monograph: COVERSYL PLUS HD (Perindopril Arginine / Indapamide)

Frequently Asked Questions (FAQ)

Common questions about Preterian (FAQ)


Q: What should I generally expect when starting Preterian?

According to the official product information, when initiating treatment or after a dose change, it's common to experience symptoms like dizziness or light-headedness due to the expected effect of lowering blood pressure. This effect is typically managed by moving slowly when changing positions.


Q: Does Preterian need to be taken long-term?

Regulatory information indicates that the medicine is typically used for sustained periods, which may be long-term, for managing high blood pressure. This continuous use is intended to maintain blood pressure control and manage the associated cardiovascular risks.


Q: What happens if I forget to take a dose of Preterian?

Regulatory guidance specifies the conditions for taking a missed dose based on the time remaining before the next scheduled dose. If the next dose is due within a specific timeframe (e.g., within six hours of the next dose time), the missed dose is typically skipped entirely, and the regular schedule is resumed. The goal is to avoid administering doses too close together.


Q: Is it normal to feel a change in appetite while taking Preterian?

A change in appetite is not listed in official documents as one of the common side effects. Loss of appetite has been noted in the documentation; however, official safety information indicates it is typically associated with documented adverse reactions involving organ systems like the liver or kidneys, and is not a common isolated side effect.


Q: Does Preterian interact with common over-the-counter pain relievers?

Yes, caution is advised. Official safety documents state that Nonsteroidal Anti-inflammatory Drugs (NSAIDs), a class that includes some common over-the-counter pain relievers, may reduce the intended blood pressure-lowering effect of Preterian. They can also increase the risk of certain kidney problems.


Q: What should I know about combining Preterian with vitamins?

Official product information emphasizes that knowledge of all products being used, including vitamins and herbal supplements, is necessary for considering potential interactions. This is to ensure all potential contraindications or precautions are known.


Q: Does Preterian affect blood sugar levels?

Official safety documents indicate that an increase in blood glucose levels (blood sugar) has been documented as a possible side effect of the medication. This finding may require monitoring, particularly if a person has existing blood sugar concerns.


Q: What happens when treatment with Preterian is stopped?

According to regulatory sources, stopping the medication will likely cause the individual's blood pressure to rise again. This increase in blood pressure can, in turn, increase the associated risk of major cardiovascular events, such as a heart attack or stroke.


Q: Is Preterian the only treatment option for this condition?

No. The official therapeutic indication is that this fixed-dose combination is generally recommended for adults who have not achieved adequate blood pressure control using single-drug treatments (known as monotherapy). This indicates that other options exist.


Q: Are there specific medical tests required before starting Preterian?

Official warnings and precautions indicate that frequent monitoring of certain blood tests is necessary while using this medication. These tests check for levels of substances like creatinine and potassium, which relate directly to the conditions under which the drug should or should not be used.


Q: Where can I find the official patient information leaflet for Preterian?

Official information intended for patients is provided in regulatory-aligned documents. These are generally referred to as the Consumer Medicine Information (CMI) or the Patient Medication Information (PMI) leaflet, which are supplied when the medicine is dispensed.


Q: Can Preterian be used by people who have existing heart conditions?

Official information states that the medicine is contraindicated (should not be used) in people with untreated decompensated heart failure—a severe condition where the heart cannot effectively pump blood. Caution and careful use are also noted for patients with other forms of severe congestive heart failure.


Q: Is Preterian suitable for use by older adults?

Studies reviewed by regulatory bodies have not identified problems specific to older adults that would limit the general usefulness of the medication. Treatment is typically initiated at the lowest available strength in this population.


Q: Can Preterian affect my ability to drive or operate machinery?

Yes. Official safety information advises caution when driving or operating machinery because the medication may cause dizziness or light-headedness. Official documentation notes that engaging in these activities should be approached cautiously until an individual is aware of how the medicine affects them.


Q: Is there a risk of becoming dependent on Preterian?

Regulatory-aligned patient information, which is based on clinical data, states that there is no evidence that this medication is addictive or that it causes drug dependency.


Q: How long do the common side effects of Preterian usually last?

The duration of side effects can differ for everyone. For example, the cough that can be associated with the perindopril component has been noted in official patient guides to potentially take up to a month to go away, even after treatment has been stopped.


Q: Why is Preterian not recommended for people with kidney disease?

Official warnings state that the medicine is not recommended in cases of severe kidney impairment. This is because its use in this population increases the risk of complications, including dangerously low blood pressure (hypotension) and severely high potassium levels (hyperkalemia).


Q: How does Preterian affect mood or behavior?

According to regulatory adverse reaction reports, mood changes and sleep disturbances have been documented as uncommon (rarely reported) side effects of the medicine.


Q: What does it mean if an interaction is listed as 'major' for Preterian?

When an interaction is classified as 'major,' it means the combination with the other substance is considered highly clinically significant. This generally indicates that the combination should be avoided because the risk of a dangerous or adverse outcome outweighs the therapeutic benefit.


Q: What is the shelf life of Preterian?

Official storage and packaging information typically states that the tablets have a shelf life of three years when they are stored correctly according to the instructions on the package.


Q: Are there any limitations on physical activity while using Preterian?

Official patient precautions describe the need to maintain adequate hydration during physical activity or in hot weather. This is to help prevent symptoms like dizziness or light-headedness that can be caused by dehydration combined with the blood pressure-lowering effect.


Q: Does Preterian require a special prescription or monitoring?

Yes, it is a prescription-only medicine. Beyond the ongoing monitoring of your blood pressure, medical professionals may require regular blood tests at follow-up visits to check for changes in your kidney function and potassium levels.


Q: What is the difference between a side effect and an adverse reaction for Preterian?

In regulatory documents, a side effect generally refers to a known or expected, troublesome symptom associated with the medicine. An adverse reaction often refers to a more severe, unexpected, or potentially life-threatening event that requires immediate medical attention.


Q: Does alcohol consumption affect Preterian?

Yes. Official information indicates that alcohol can have an additive effect on the blood pressure-lowering action of the drug. This may increase the likelihood of experiencing symptoms such as dizziness, headache, or fainting.


Q: Are there common reasons why people might stop taking Preterian?

Official documentation specifies that discontinuation of the medication is required if pregnancy is detected. Discontinuation is also required if serious, life-threatening adverse reactions occur, such as swelling of the face, throat, or tongue (angioedema).

How should Preterian be stored and disposed of?

The official storage and disposal instructions for Preterian tablets are established by regulatory documents to preserve the integrity of the medication.

Storage Conditions

Requirement Official Instruction
Temperature Store at room temperature, typically below 25 C (77 F); do not freeze the tablets.
Protection The medicine must be protected from moisture and humidity.
Packaging Keep the tablets in the original blister pack or container and keep the container tightly closed.

Child Safety and Disposal

Preterian must be stored strictly out of the sight and reach of children and pets.

Unused or expired tablets should be discarded using a drug take-back program or mail-back service. If these options are unavailable, the medicine must be mixed with an undesirable substance and placed in a sealed container for disposal in the household trash. Do not dispose of the medicine by flushing down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Preterian found in:

A-Z Index: